Keiyu Matsumoto

Systematic chemical screening identifies disulfiram as a repurposed drug that enhances sensitivity to cisplatin in bladder cancer: a summary of preclinical studies

Yuki Kita, Akihiro Hamada, Ryoichi Saito et al. · British Journal of Cancer · 2019 · 63 citations · Full text

Medicine, Oncology, Pharmacology +17

Trp53 Mutation in Keratin 5 (Krt5)-Expressing Basal Cells Facilitates the Development of Basal Squamous-Like Invasive Bladder Cancer in the Chemical Carcinogenesis of Mouse Bladder

Norihiko Masuda, Kaoru Murakami, Yuki Kita et al. · American Journal Of Pathology · 2020 · 34 citations · Full text

Medicine, Molecular Biology, Oncology +14

Antitumor effect of WEE1 blockade as monotherapy or in combination with cisplatin in urothelial cancer

Kaoru Murakami, Yuki Kita, Toru Sakatani et al. · Cancer Science · 2021 · 13 citations · Full text

Medicine, Oncology, Pharmacology +15

242 The predictive value of C-reactive protein on prognosis of patients with upper tract urothelial carcinoma treated with radical nephroureterectomy: Multi-institutional study

Eiji Kikuchi, Nobue Tanaka, Suguru Shirotake et al. · European Urology Supplements · 2013 · 12 citations

Medicine, Oncology, Urology +16

Efficacy of Immediate Postoperative Instillation of Chemotherapy for Primary Non–Muscle-Invasive Bladder Cancer in Real-World Clinical Practice

Kaoru Murakami, Akihiro Hamada, Yuki Teramoto et al. · Clinical Genitourinary Cancer · 2019 · 10 citations

Medicine, Oncology, Urology +13